Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
TEL AVIV STOCK EXCHANGE
10:29:55 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 11,120.00 ILa | -0.09% |
|
+1.09% | +10.21% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-03 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.36B 0 36.43B 34.37B 31.31B 58.53B 4,050B 59.06B 409B 158B 2,054B 159B 156B 6,524B | P/E 2026 * |
52.1x | P/E 2027 * | 21.5x |
|---|---|---|---|---|---|
| Enterprise Value | 54.26B 0 46.66B 44.03B 40.11B 74.98B 5,188B 75.66B 524B 202B 2,631B 204B 199B 8,358B | EV / Sales 2026 * |
3.27x | EV / Sales 2027 * | 2.95x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | -0.09% | ||
| 1 week | +1.09% | ||
| Current month | +3.83% | ||
| 1 month | +4.41% | ||
| 3 months | +9.88% | ||
| 6 months | +13.83% | ||
| Current year | +10.21% |
| 1 week | 10,680 |  | 11,260 |
| 1 month | 10,650 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | 52 | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 65 | 2015-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +1.09% | - | - | 42.94B | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,002B | |
| -0.27% | -4.34% | +51.52% | +65.89% | 644B | |
| +1.63% | -2.00% | +20.49% | +71.12% | 443B | |
| -0.63% | -3.09% | +29.84% | +34.59% | 343B | |
| +0.43% | -14.61% | +11.32% | +27.26% | 262B | |
| +0.93% | -3.19% | -1.31% | +8.41% | 245B | |
| -2.25% | -13.88% | +37.33% | +47.43% | 212B | |
| -0.90% | -5.06% | -18.47% | -57.75% | 199B | |
| -0.58% | -4.24% | +25.65% | +90.54% | 181B | |
| Average | -0.11% | -5.18% | +22.80% | +42.11% | 392.19B | |
| Weighted average by Cap. | +0.07% | -4.39% | +31.98% | +57.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.6B 0 14.28B 13.47B 12.27B 22.94B 1,587B 23.15B 160B 61.75B 805B 62.34B 60.98B 2,557B | 17.32B 0 14.89B 14.05B 12.8B 23.93B 1,656B 24.15B 167B 64.41B 840B 65.03B 63.61B 2,668B |
| Net income | 1.27B 0 1.1B 1.03B 942M 1.76B 122B 1.78B 12.32B 4.74B 61.82B 4.79B 4.68B 196B | 2.43B 0 2.09B 1.97B 1.8B 3.36B 233B 3.39B 23.51B 9.05B 118B 9.14B 8.94B 375B |
| Net Debt | 11.9B 0 10.24B 9.66B 8.8B 16.45B 1,138B 16.6B 115B 44.27B 577B 44.7B 43.72B 1,833B | 8.65B 0 7.44B 7.02B 6.4B 11.96B 827B 12.06B 83.61B 32.18B 420B 32.49B 31.78B 1,333B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | ILA 11,120.00 | -0.09% | 1,052,520 |
| 26-09-09 | ILA 11,130.00 | +1.92% | 1,048,196 |
| 26-09-08 | ILA 10,920.00 | +0.09% | 1,086,826 |
| 26-09-07 | ILA 10,910.00 | -0.46% | 499,288 |
| 26-09-04 | ILA 10,960.00 | -0.36% | 473,654 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
